基本信息
views: 107
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Professor Julian Rayner, whose research at the Wellcome Sanger Institute has made significant contributions to our understanding of malaria parasites, took over as Director of the Cambridge Institute of Medical Research (CIMR) on 1 May 2019.
The CIMR is one of the flagship non-clinical research facilities on the Cambridge Biomedical Campus. It brings together clinicians and non-clinical researchers in a mutually productive partnership, using cell biology to understand the cellular basis of disease, and studying genetic disease to reveal crucial mechanisms of cell biology.
Julian’s research helps to identify new malaria drug and vaccine targets by investigating the interactions between Plasmodium parasites – the organism that causes malaria – and human red blood cells. After undergraduate education in New Zealand and a PhD at the MRC Laboratory of Molecular Biology in Cambridge, he began working on malaria cell biology as a postdoctoral fellow at the Centers for Disease Control and Prevention in Atlanta, followed by his first faculty position at the University of Alabama at Birmingham.
Since 2008 he has been a Group Leader at the Wellcome Sanger Institute, during which time he and collaborators have identified an essential protein complex involved in the invasion of red blood cells by malaria parasites. This is now in early stage human vaccine testing. They have also traced the origins of human malaria parasites in African apes, and carried out the first ever genome-scale genetic screenings in Plasmodium parasites, helping to identify new targets for drug development.
At the Sanger Institute, Julian was Director of Graduate Studies from 2012 to 2014 and since 2014 has been Director of Wellcome Genome Campus Connecting Science, a multidisciplinary training and engagement programme which aims to enable everyone to explore genomics and its impact on research, health and society. He is strongly committed to public engagement and will maintain his role with Connecting Science while at CIMR, helping to forge even stronger links between the University of Cambridge and the Wellcome Genome Campus.
The CIMR is one of the flagship non-clinical research facilities on the Cambridge Biomedical Campus. It brings together clinicians and non-clinical researchers in a mutually productive partnership, using cell biology to understand the cellular basis of disease, and studying genetic disease to reveal crucial mechanisms of cell biology.
Julian’s research helps to identify new malaria drug and vaccine targets by investigating the interactions between Plasmodium parasites – the organism that causes malaria – and human red blood cells. After undergraduate education in New Zealand and a PhD at the MRC Laboratory of Molecular Biology in Cambridge, he began working on malaria cell biology as a postdoctoral fellow at the Centers for Disease Control and Prevention in Atlanta, followed by his first faculty position at the University of Alabama at Birmingham.
Since 2008 he has been a Group Leader at the Wellcome Sanger Institute, during which time he and collaborators have identified an essential protein complex involved in the invasion of red blood cells by malaria parasites. This is now in early stage human vaccine testing. They have also traced the origins of human malaria parasites in African apes, and carried out the first ever genome-scale genetic screenings in Plasmodium parasites, helping to identify new targets for drug development.
At the Sanger Institute, Julian was Director of Graduate Studies from 2012 to 2014 and since 2014 has been Director of Wellcome Genome Campus Connecting Science, a multidisciplinary training and engagement programme which aims to enable everyone to explore genomics and its impact on research, health and society. He is strongly committed to public engagement and will maintain his role with Connecting Science while at CIMR, helping to forge even stronger links between the University of Cambridge and the Wellcome Genome Campus.
Research Interests
Papers共 258 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Emma Kals, Morten Kals, Rebecca A. Lees,Viola Introini,Alison Kemp,Eleanor Silvester,Christine R. Collins,Trishant Umrekar,Jurij Kotar,Pietro Cicuta,Julian C. Rayner
biorxiv(2024)
Sébastien Charneau,Lucas Silva de Oliveira,Zenon Zenonos,Christine S Hopp,Izabela M D Bastos,Damarys Loew,Bérangère Lombard,Ariane Pandolfo Silveira, Giovanna de Carvalho Nardeli Basílio Lobo,Sônia Nair Bao,Philippe Grellier,Julian C Rayner
Scientific reportsno. 1 (2024): 11242-11242
Emma Kals, Morten Kals, Rebecca A. Lees,Viola Introini,Alison Kemp,Eleanor Silvester,Christine R. Collins,Trishant Umrekar,Jurij Kotar,Pietro Cicuta,Julian C. Rayner
crossref(2024)
Patrycja Burzyńska, Zbigniew Darżynkiewicz, Tomasz Lipiński,Agata Zerka,Marlena Jodłowska,Julian Rayner,Ewa Jaśkiewicz
crossref(2024)
The Journal of infectious diseases (2024)
Trends in Parasitology (2024)
Nature communicationsno. 1 (2023): 5703-17
Scientific reportsno. 1 (2023): 20788-20788
Load More
Author Statistics
#Papers: 260
#Citation: 12469
H-Index: 56
G-Index: 109
Sociability: 7
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn